GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.
GENIL | IS
Overview
Corporate Details
- ISIN(s):
- TREGENL00016 (+1 more)
- LEI:
- 789000A4NW6W4D8Z4H25
- Country:
- Türkiye
- Address:
- MUSTAFA KEMAL MAH. 2119. SOK. NO;3 D:2-3 ÇANKAYA/ANKARA, 06520 ANKARA
- Website:
- https://www.genilac.com.tr
- Sector:
- Health Care
- Industry:
- Health Care Equipment & Supplies
Description
Gen Ilac produces pharmaceuticals and healthcare products, supporting public health with innovative solutions.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-28 14:05 |
Regulatory News Service
Updates on the SUL-238 Project
|
Turkish | 21.2 KB | |
| 2025-07-14 18:06 |
Regulatory News Service
İç Kaynaklardan Bedelsiz Sermaye Arttırımı Hk.
|
Turkish | 18.5 KB | |
| 2025-07-07 08:14 |
Regulatory News Service
State Supply Office Tender Notification
|
Turkish | 19.0 KB | |
| 2025-07-03 17:10 |
Regulatory News Service
Collateral
|
Turkish | 20.5 KB | |
| 2025-06-26 16:19 |
Proxy Solicitation & Information Statements
Solar Power Plant Project Update
|
Turkish | 23.0 KB | |
| 2025-06-11 14:35 |
Proxy Solicitation & Information Statements
Additional Investment on RS Research
|
English | 94.4 KB | |
| 2025-06-02 17:15 |
Capital/Financing Update
Application to Capital Markets Board of Türkiye for Issuance of Debt Securities.
|
English | 4.4 KB | |
| 2025-05-23 17:12 |
Capital/Financing Update
Decision of the Board of Directors for Application to the Capital Markets Board…
|
English | 4.4 KB | |
| 2025-05-23 17:12 |
Capital/Financing Update
Kira Sertifikası İhracı İçin Yönetim Kurulu Kararı
|
Turkish | 5.0 KB | |
| 2025-05-22 16:54 |
Quarterly Report
2025 Q1 Analyst Presentation
|
English | 2.3 MB | |
| 2025-05-22 16:54 |
Quarterly Report
2025 Q1 Analyst Presentation
|
Turkish | 2.6 MB | |
| 2025-05-22 16:54 |
Proxy Solicitation & Information Statements
2025 Q1 Analyst Presentation
|
English | 17.1 KB | |
| 2025-05-15 17:21 |
Proxy Solicitation & Information Statements
Statement made by Abidin GÜLMÜŞ
|
Turkish | 21.7 KB | |
| 2025-05-14 12:49 |
Proxy Solicitation & Information Statements
Tender Result Notified by the Organization which Authorized by Our Company
|
Turkish | 19.0 KB | |
| 2025-05-13 09:40 |
Proxy Solicitation & Information Statements
Solar Power Plant Project Update
|
Turkish | 20.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Gvs | Italy | GVS | |
|
Haleon PLC | United Kingdom | HLN | |
|
I.Ceram | France | ALICR | |
|
NanoRepro AG | Germany | NN6 | |
|
PolyPeptide Group AG | Switzerland | PPGN | |
|
Safe S.A. | France | ALSAF | |
|
Sartorius Stedim Biotech | France | DIM | |
|
SKAN Group AG | Switzerland | SKAN | |
|
Slavej AD | North Macedonia | SLAV | |
|
Zur Rose Group AG | Switzerland | ROSE |